Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors

Summary

This is an open label phase 1b maintenance therapy study to evaluate the long-term safety, immunogenicity, and anti-tumor effects of repeat-dose vaccination with ONT-10 in patients who have demonstrated safety and clinical benefit on the original ONT-10-001 phase 1 study.

Timeline

Start

2012-11

Primary completion

2016-03

Completion

2016-03

Drugs

Indications